Details of the Drug
General Information of Drug (ID: DMUF16A)
Drug Name |
(9H-beta-Carbolin-3-yl)-methanol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-hydroxymethyl-beta-carboline; 65474-79-5; UNII-00QJ5EQT3E; 9H-pyrido[3,4-b]indol-3-ylmethanol; 00QJ5EQT3E; 3-HMC; 3-(hydroxymethyl)-beta-carboline; 3-HYDROXYMETHYL-b-CARBOLINE; 9H-Pyrido[3,4-b]indole-3-methanol; 9H-pyrido(3,4-b)indole-3-methanol; Prestwick_970; Biomol-NT_000286; AC1NS42Q; DivK1c_000628; 9H-beta-carboline-3-methanol; CHEMBL417982; SCHEMBL2216848; BPBio1_001234; KBio1_000628; CTK2F5969; HMS501P10; DTXSID20215795; MolPort-005-942-230; CPBYHTDUBNSBQM-UHFFFAOYSA-N; CHEBI:114188; NINDS_000628; ZINC11535632
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 198.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||